{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:46:20Z","timestamp":1782823580763,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03712-w","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T08:02:27Z","timestamp":1724140947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Alexia","family":"Steelandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambre","family":"Hittinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukshe","family":"Kanagaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efs","family":"Bolko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"4","key":"3712_CR1","doi-asserted-by":"publisher","first-page":"e006843","DOI":"10.1136\/bmjopen-2014-006843","volume":"5","author":"W Wang","year":"2015","unstructured":"Wang W, Bhole VM, Krishnan E. Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study. BMJ Open. 2015;5(4):e006843.","journal-title":"BMJ Open."},{"key":"3712_CR2","doi-asserted-by":"publisher","first-page":"911968","DOI":"10.3389\/fendo.2022.911968","volume":"13","author":"Y Mei","year":"2022","unstructured":"Mei Y, Dong B, Geng Z, Xu L. Excess uric acid induces gouty nephropathy through crystal formation: a review of recent insights. Front Endocrinol (Lausanne). 2022;13:911968.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"3712_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2169\/internalmedicine.44.706","volume":"44","author":"I Ohno","year":"2005","unstructured":"Ohno I, Ichida K, Okabe H, Hikita M, Uetake D, Kimura H, et al. Frequency of gouty arthritis in patients with end-stage renal disease in Japan. Intern Med. 2005;44(7):706\u20139.","journal-title":"Intern Med"},{"key":"3712_CR4","doi-asserted-by":"crossref","unstructured":"Andr\u00e9s M, Soriano R, Oliveira E, Trigo C, Arenas M, Pascual E. THU0406 Serum uric acid lowering treatment appears unnecessary during hemodialysis. In: Poster Presentations. BMJ Publishing Group Ltd and European League Against Rheumatism; 2017. p. 361.1-361. Disponible sur:\u00a0https:\/\/ard.bmj.com\/lookup\/doi\/10.1136\/annrheumdis-2017-eular.2392. Cit\u00e9 5 juill 2023.","DOI":"10.1136\/annrheumdis-2017-eular.2392"},{"issue":"2","key":"3712_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.34067\/KID.0004132022","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Kshirsagar O, Marder BA, Cohen AR, LaMoreaux B, Bleyer AJ. Gout among patients with dialysis: prevalence, associated factors, treatment patterns, and outcomes-population-based retrospective cohort study. Kidney360. 2023;4(2):177\u201387.","journal-title":"Kidney360."},{"issue":"11","key":"3712_CR6","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1681\/ASN.2007111256","volume":"19","author":"SD Cohen","year":"2008","unstructured":"Cohen SD, Kimmel PL, Neff R, Agodoa L, Abbott KC. Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol. 2008;19(11):2204\u201310.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3712_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ndt\/gfu352","volume":"30","author":"J Jing","year":"2015","unstructured":"Jing J, Kielstein JT, Schultheiss UT, Sitter T, Titze SI, Schaeffner ES, et al. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study. Nephrol Dial Transplant. 2015;30(4):613\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"3712_CR8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/imj.14163","volume":"49","author":"E Yeo","year":"2019","unstructured":"Yeo E, Palmer SC, Chapman PT, Frampton C, Stamp LK. Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional study. Intern Med J. 2019;49(7):838\u201342.","journal-title":"Intern Med J"},{"issue":"3\u20134","key":"3712_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000530972","volume":"54","author":"SH Kang","year":"2023","unstructured":"Kang SH, Kim BY, Son EJ, Kim GO, Do JY. Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis. Am J Nephrol. 2023;54(3\u20134):117\u201325.","journal-title":"Am J Nephrol"},{"issue":"1","key":"3712_CR10","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/0886022X.2020.1835674","volume":"42","author":"B Rohn","year":"2020","unstructured":"Rohn B, Jansing W, Seibert FS, Pfab T, Cinkilic O, Pa\u00dffall J, et al. Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients. Ren Fail. 2020;42(1):1067\u201375.","journal-title":"Ren Fail"},{"issue":"11","key":"3712_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/jcph.939","volume":"57","author":"E Rutherford","year":"2017","unstructured":"Rutherford E, Stewart G, Houston JG, Jardine AG, Mark PB, Struthers AD. An open-label dose-finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients. J Clin Pharmacol. 2017;57(11):1409\u201314.","journal-title":"J Clin Pharmacol"},{"key":"3712_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40780-015-0028-1","volume":"1","author":"S Mitsuboshi","year":"2015","unstructured":"Mitsuboshi S, Yamada H, Nagai K, Okajima H. Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patients. J Pharm Health Care Sci. 2015;1:28.","journal-title":"J Pharm Health Care Sci"},{"issue":"1","key":"3712_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10157-012-0763-7","volume":"17","author":"R Horikoshi","year":"2013","unstructured":"Horikoshi R, Akimoto T, Inoue M, Morishita Y, Kusano E. Febuxostat for hyperuricemia: experience with patients on chronic hemodialysis treatment. Clin Exp Nephrol. 2013;17(1):149\u201350.","journal-title":"Clin Exp Nephrol"},{"key":"3712_CR14","doi-asserted-by":"publisher","first-page":"bcr0220125814","DOI":"10.1136\/bcr.02.2012.5814","volume":"2012","author":"RO Day","year":"2012","unstructured":"Day RO, Kannangara DRW, Hayes JM, Furlong TJ. Successful use of allopurinol in a patient on dialysis. BMJ Case Rep. 2012;2012:bcr0220125814.","journal-title":"BMJ Case Rep."},{"issue":"1","key":"3712_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/1319-2442.198278","volume":"28","author":"HM Amine","year":"2017","unstructured":"Amine HM. Tophi as the initial manifestation of gout in a normouricemic hemodialysis patient: an unusual case of a common disorder. Saudi J Kidney Dis Transpl. 2017;28(1):194\u20135.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"3712_CR16","first-page":"9106935","volume":"2016","author":"LA Frassetto","year":"2016","unstructured":"Frassetto LA, Gibson S. Febuxostat and increased dialysis as a treatment for severe tophaceous gout in a hemodialysis patient. Case Rep Nephrol. 2016;2016:9106935.","journal-title":"Case Rep Nephrol"},{"issue":"3","key":"3712_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/imj.14776","volume":"51","author":"SY Choi","year":"2021","unstructured":"Choi SY, Choi SW, Lee S, So MW, Oh JS, Lim DH. Efficacy and tolerability of febuxostat in gout patients on dialysis. Intern Med J mars. 2021;51(3):348\u201354.","journal-title":"Intern Med J mars"},{"key":"3712_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00002480-196504000-00047","volume":"11","author":"CP Hayes","year":"1965","unstructured":"Hayes CP, Metz EN, Robinson RR, Rundles RW. The use of allopurinol (HPP) to control hyperuricemia in patients on chronic intermittent hemodialysis. Trans Am Soc Artif Intern Organs. 1965;11:247\u201354.","journal-title":"Trans Am Soc Artif Intern Organs"},{"issue":"9","key":"3712_CR19","first-page":"618","volume":"54","author":"WJ Johnson","year":"1979","unstructured":"Johnson WJ, O\u2019Duffy JD. Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol. Mayo Clin Proc. 1979;54(9):618\u201320.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"3712_CR20","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.21037\/apm-22-628","volume":"11","author":"J Ma","year":"2022","unstructured":"Ma J, Huang J, Bao S, Zhang A, Dai L, Yu Q, et al. The safety and urate-lowering efficacy of febuxostat in patients undergoing peritoneal dialysis: a retrospective single-arm cohort study of 84 patients. Ann Palliat Med. 2022;11(7):2443\u201350.","journal-title":"Ann Palliat Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03712-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T11:25:02Z","timestamp":1724325902000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03712-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3712"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03712-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to current French law for non-interventional retrospective studies, no ethical approval or consent to participate was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}